⌘K
Loading ticker…
Longeveron Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Longeveron Inc. Common Stock (LGVN) has a 3-month relative strength percentile of 13 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.2%, relative volume 1.46×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
13 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
LGVN is in a stage 1 base, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -12.9% / -4.1%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
LGVN is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $376K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $376K |
| VXFVanguard Extended Market ETF | 0.00% | $188K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LGVN Jan avg: -8.82% median: -0.18% win: 50% σ: 37.48% n: 4 2022-04-12 → 2026-05-29 | LGVN Feb avg: -4.22% median: -2.28% win: 0% σ: 4.89% n: 4 2022-04-12 → 2026-05-29 | LGVN Mar avg: 7.38% median: -11.72% win: 50% σ: 59.01% n: 4 2022-04-12 → 2026-05-29 | LGVN Apr avg: -7.36% median: 8.24% win: 60% σ: 25.47% n: 5 2022-04-12 → 2026-05-29 | LGVN May avg: -17.42% median: -18.46% win: 20% σ: 14.77% n: 5 2022-04-12 → 2026-05-29 | LGVN Jun avg: 9.49% median: 9.51% win: 75% σ: 30.36% n: 4 2022-04-12 → 2026-05-29 (current) | LGVN Jul avg: 30.50% median: 14.84% win: 75% σ: 44.07% n: 4 2022-04-12 → 2026-05-29 | LGVN Aug avg: -30.50% median: -29.01% win: 0% σ: 14.69% n: 4 2022-04-12 → 2026-05-29 | LGVN Sep avg: -13.43% median: -13.07% win: 0% σ: 7.86% n: 4 2022-04-12 → 2026-05-29 | LGVN Oct avg: 0.23% median: 2.79% win: 50% σ: 12.09% n: 4 2022-04-12 → 2026-05-29 | LGVN Nov avg: -3.91% median: -1.21% win: 25% σ: 11.70% n: 4 2022-04-12 → 2026-05-29 | LGVN Dec avg: -21.75% median: -20.39% win: 0% σ: 6.90% n: 4 2022-04-12 → 2026-05-29 |